News | Page 20 | Englander Institute for Precision Medicine

Microscopic image of metastatic clear cell carcinoma of kidney, the most common type of renal cell carcinoma. Credit: Shutterstock

Finding Innovative Ways to Address Kidney Cancer Leads to DoD Grant

December 10, 2024

Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.

The grant is one of 10 Idea Awards the department funded this year to support innovative, high-risk, high-reward science that could lead to a paradigm shift in cancer care. The funding will enable principal investigators Dr...

Landmark AI Project Harnesses Voice to Diagnose Disease, Releases First Data

December 2, 2024

Researchers at USF Health and Weill Cornell Medicine, as part of an expansive, multi-institutional project investigating voice as a biomarker for disease, have reached a significant milestone by publishing the first version of their clinically validated voice dataset to an online artificial intelligence platform where it will be an invaluable resource for researchers across the globe.

The National Institutes of Health-funded project, ...

Prostate cancer cells with low levels of PKCλ/ι (turquoise) show increased EZH2 expression (magenta). Credit: Dr. Tania Cid-Diaz

Study Unveils Key Strategies Against Drug-Resistant Prostate Cancer

November 20, 2024

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The results could potentially lead to new therapies for patients with limited options and add to the significant progress the teams have made in understanding how advanced...